NO980623L - Fremgangsmåte for å bestemme graden av aggregering av <beta>A4-peptidet - Google Patents

Fremgangsmåte for å bestemme graden av aggregering av <beta>A4-peptidet

Info

Publication number
NO980623L
NO980623L NO980623A NO980623A NO980623L NO 980623 L NO980623 L NO 980623L NO 980623 A NO980623 A NO 980623A NO 980623 A NO980623 A NO 980623A NO 980623 L NO980623 L NO 980623L
Authority
NO
Norway
Prior art keywords
aggregation
peptide
beta
determining
degree
Prior art date
Application number
NO980623A
Other languages
English (en)
Norwegian (no)
Other versions
NO980623D0 (no
Inventor
Shefali Goyal
Joseph West Paul
Norbert Guenther Riedel
Sudhir Ramchandra Sahasrabudhe
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO980623L publication Critical patent/NO980623L/no
Publication of NO980623D0 publication Critical patent/NO980623D0/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
NO980623A 1995-08-16 1998-02-13 Fremgangsmåte for å bestemme graden av aggregering av <beta>A4-peptidet NO980623D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51560695A 1995-08-16 1995-08-16
PCT/US1996/012034 WO1997007403A1 (en) 1995-08-16 1996-07-23 A METHOD OF DETERMINING THE DEGREE OF AGGREGATION OF THE βA4 PEPTIDE

Publications (2)

Publication Number Publication Date
NO980623L true NO980623L (no) 1998-02-13
NO980623D0 NO980623D0 (no) 1998-02-13

Family

ID=24052039

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980623A NO980623D0 (no) 1995-08-16 1998-02-13 Fremgangsmåte for å bestemme graden av aggregering av <beta>A4-peptidet

Country Status (19)

Country Link
EP (1) EP0846269B1 (de)
JP (1) JP3042895B2 (de)
KR (1) KR19990036439A (de)
CN (1) CN1107230C (de)
AR (1) AR003251A1 (de)
AT (1) ATE250766T1 (de)
AU (1) AU697842B2 (de)
CA (1) CA2229187C (de)
DE (1) DE69630131T2 (de)
DK (1) DK0846269T3 (de)
ES (1) ES2206586T3 (de)
HK (1) HK1015030A1 (de)
IL (1) IL122759A (de)
NO (1) NO980623D0 (de)
NZ (1) NZ313070A (de)
PT (1) PT846269E (de)
TW (1) TW574503B (de)
WO (1) WO1997007403A1 (de)
ZA (1) ZA966808B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60336848D1 (de) * 2002-09-12 2011-06-01 Univ California Immunogene und entsprechende antikörper, die spezifisch sind für häufige hochmolekulare aggregations-zwischenprodukte von amyloiden aus proteinen unterschiedlicher sequenz
EP3147668B1 (de) * 2014-05-22 2019-12-11 Shimadzu Corporation Surrogatbiomarker zur beurteilung der intrazerebralen amyloid -beta-peptidakkumulation und verfahren zur analyse davon
CN104729946A (zh) * 2014-12-18 2015-06-24 江苏大学 一种检测淀粉样多肽聚集及其聚集抑制剂评估的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816416A (en) * 1986-08-27 1989-03-28 Paul Averback Microspheric bodies for use in screening therapies for Azheimer's disease and related conditions
AU7556994A (en) * 1993-08-13 1995-03-14 Molecular Geriatrics Corporation Methods for the diagnosis of alzheimer's disease
US5744368A (en) * 1993-11-04 1998-04-28 Research Foundation Of State University Of New York Methods for the detection of soluble amyloid β-protein (βAP) or soluble transthyretin (TTR)

Also Published As

Publication number Publication date
CA2229187C (en) 2003-03-18
CN1107230C (zh) 2003-04-30
TW574503B (en) 2004-02-01
WO1997007403A1 (en) 1997-02-27
JP3042895B2 (ja) 2000-05-22
HK1015030A1 (en) 1999-10-08
KR19990036439A (ko) 1999-05-25
IL122759A0 (en) 1998-08-16
CN1193385A (zh) 1998-09-16
NZ313070A (en) 1999-01-28
EP0846269A1 (de) 1998-06-10
IL122759A (en) 2003-05-29
ATE250766T1 (de) 2003-10-15
AU697842B2 (en) 1998-10-15
AU6505296A (en) 1997-03-12
MX9801255A (es) 1998-05-31
ZA966808B (en) 1997-02-19
NO980623D0 (no) 1998-02-13
DK0846269T3 (da) 2003-12-01
JPH11501398A (ja) 1999-02-02
DE69630131T2 (de) 2004-07-08
CA2229187A1 (en) 1997-02-27
ES2206586T3 (es) 2004-05-16
AR003251A1 (es) 1998-07-08
DE69630131D1 (de) 2003-10-30
PT846269E (pt) 2004-01-30
EP0846269B1 (de) 2003-09-24

Similar Documents

Publication Publication Date Title
NO973982D0 (no) Fremgangsmåte for fremstilling av heteromultimere polypeptider
NO970153L (no) Fremgangsmåte for syntese av substituerte sulfoksider
NO962750L (no) Fremgangsmåte for fremstilling av buten-1
NO975057D0 (no) Fremgangsmåte for fremstilling av vinylacetat
EP0880597A4 (de) THERAPEUTISCHE VERWENDUNGEN VON DEM ANTI-T-BAM(CD40-L)MONOKLONALEN ANTIKORPER-5c8
NO981800D0 (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
AU672379B2 (en) Diagnostic assay for Alzheimer&#39;s Disease based on the proteolysis of Alzheimer&#39;s precursor protein
LV11630A (lv) T sunu antigena receptora V apgabala pilna garuma olbaltumvielas
AU5686698A (en) Methods for the production of chicken monoclonal antibodies
NO306620B1 (no) Fremgangsmåte for fremstilling av polydimetylsiloksaner
AU7258496A (en) Coiled-coil heterodimer methods and compositions for the detection and purification of expressed proteins
NO986086D0 (no) FremgangsmÕte for fremstilling av 17-estere av 9&lt;alfa&gt;,21-dihalo-pregnan-11
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
AU5932796A (en) Hierarchical protein folding prediction
AU5635896A (en) Recombinant endotoxin-neutralizing proteins
AU4583397A (en) Assay for the detection of antibodies against p53
NO980623L (no) Fremgangsmåte for å bestemme graden av aggregering av &lt;beta&gt;A4-peptidet
FI972763A (fi) Mutanttiproteiineja
AU5058196A (en) Process for the preparation of 1,1-difluoroethane
AU4743496A (en) Peptides specific for the first crk-sh3 domain
AU1055997A (en) Luminescent probes for protein detection
NO985535L (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
AU4811797A (en) Chimeric lepidopteran-toxic crystal proteins
NO974747D0 (no) Fremgangsmåte for fremstilling av streptograminer
NO972682D0 (no) Ny fremgangsmåte for fremstilling av sameridin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application